Medibus from VDL Bus & Coach serves as mobile laboratory in fight against COVID-19

Medibus from VDL Bus & Coach serves as mobile laboratory in fight against COVID-19

29 May 2020

The Deutsche Bahn (DB) Medibuses, built by VDL Bus & Coach, are currently being used in a large-scale study by the Robert Koch Institute (RKI) into the spread of COVID-19 in Germany. By using the Medibuses, researchers and physicians have access to high-quality laboratory environments, which can also be flexibly deployed in different locations.

The main objectives of the so-called ‘Corona-Monitoring lokal’ study are to map the spread of the virus and to obtain a more complete picture of the number of unreported coronavirus cases. A total of 8000 citizens from four different areas of Germany are being monitored.

“DB Medibus is a cross-company joint project that is made possible in particular by the expertise and commitment of our partners Cisco and VDL, say Felix Thielmann and Arndt Hecker, respectively branche manager replacement transport and business development manager at Deutsche Bahn. “We are very pleased that our Medibus, with its equipment and technical functionality, can currently make an active contribution to the research into the spread of COVID-19 in Germany".

"As a manufacturer, we very much welcome the fact that Deutsche Bahn's Medibuses are now also being used in the fight against coronavirus," says Mark Francot, director of VDL Bus Venlo. "The fact that we at VDL Bus & Coach can contribute to COVID-19 research through good cooperation between several companies makes us very proud. At the same time, this project once again endorses the multiple uses of this innovative vehicle. The Medibus fits perfectly within our Special Vehicles department."

Research in COVID-19 areas

The village of Kupferzell, in the state of Baden-Württemberg, is the first research site that the RKI arrived at with the Medibus. A church concert was held here at the beginning of March, during which 82 people became infected with coronavirus. Because of this outbreak, Kupferzell instantly became one of Germany's coronavirus hotspots. The RKI is now investigating, among other things, how many inhabitants of the village have built up antibodies against the virus and how many of them have been infected without developing any symptoms. A coronavirus test is therefore being performed on 2000 residents. Blood samples are also taken and the residents are asked for their medical history and social contacts. Participation in the study is entirely voluntary.

In addition to the 2000 residents of Kupferzell, thousands of people from three other areas affected by coronavirus are also being monitored. These areas are selected on the basis of the latest situation just before the start of the local research. During these various local studies, the Medibuses function as mobile research centres equipped with all conveniences.

A fully-fledged medical practice

The Medibuses for Deutsche Bahn were built by VDL Bus Venlo in cooperation with VDL Bus Heerenveen and VDL Bus Chassis. The Citea LLE-127 has been designed entirely according to the wishes of the customer, Deutsche Bahn. The bus has been converted into a doctor's practice in which the 4 rooms (treatment room, consultation room, laboratory and waiting room) are equipped with cupboards and furniture. Each room also has its own air conditioning, and solar panels on the roof provide clean energy so that the bus is less dependent on external power on location.

German Mobility Award 2019

In October 2019, the DB Medibus won the prestigious German Mobility Award. This award is presented annually to projects that make a significant contribution to participation and quality of life in Germany. With its 12.7 metre-long medical practice, Deutsche Bahn is making an innovative contribution to the improvement of the medical infrastructure in Germany. Initially, the DB Medibus was used for medical care in rural areas. In the meantime, numerous applications have demonstrated that the bus can also be used for many other purposes within the healthcare sector.

Back to overview